AMOLYT PHARMA
FranceEntry
2014
Hold
10yr
Exit
2024
Who owns AMOLYT PHARMA?
AMOLYT PHARMA was owned by Turenne Groupe through Capital Santé 2 (2020 vintage) from 2014 to 2024, exited via Trade Sale. Across its history, AMOLYT PHARMA has been through 5 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Turenne GroupeCapital Santé 2 · 2020 · Growth
5 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2024.
- ·Average hold across 5 realized cycles: 6 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Exited
Last exited in 2024 to .
Co-invest · 5 holders · 2014 · 2024
Sofinnova PartnersExited 2024
2021 · 2024(3yr) · Sofinnova Crossover Fund I · 2018 · VC
Trade Sale · to
MOIC
–
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
USTrack Amolyt Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Amolyt Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue